- Extracellular Vesicles as Mediators in Atherosclerotic Cardiovascular Disease
-
Zisser L, Binder CJ
- KMID: 2559851
- J Lipid Atheroscler.
- 2024 Sep;13(3):232-261.
- doi: 10.12997/jla.2024.13.3.232
Atherosclerosis is a chronic inflammatory disease of the arterial intima, characterized by accumulation of lipoproteins and accompanying inflammation, leading to the formation of plaques that eventually trigger occlusive thrombotic events,... -
- CITED
-
- Close
- SHARE
-
- Close
- Emerging Circulating Biomarkers for Enhanced Cardiovascular Risk Prediction
-
Lee DY
- KMID: 2559852
- J Lipid Atheroscler.
- 2024 Sep;13(3):262-279.
- doi: 10.12997/jla.2024.13.3.262
Cardiovascular disease (CVD) continues to be the primary cause of mortality worldwide, underscoring the importance of identifying additional cardiovascular risk factors. The consensus is that lipid levels alone do not... -
- CITED
-
- Close
- SHARE
-
- Close
- 2024 KSoLA Consensus on Secondary Dyslipidemia
-
Won H, Bae JH, Lim H, Kang M, Kim M, Lee SH, on behalf of the Clinical Practice Guidelines Committee, Korean Society of Lipid and Atherosclerosis (KSoLA)
- KMID: 2559850
- J Lipid Atheroscler.
- 2024 Sep;13(3):215-231.
- doi: 10.12997/jla.2024.13.3.215
Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes... -
- CITED
-
- Close
- SHARE
-
- Close
- Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review
-
Wai KW, Low LE, Goh BH, Yap WH
- KMID: 2559854
- J Lipid Atheroscler.
- 2024 Sep;13(3):292-305.
- doi: 10.12997/jla.2024.13.3.292
Nuclear factor erythroid 2-related factor 2 (Nrf2), a transcriptional factor that maintains intracellular redox equilibrium, modulates the expression of antioxidant genes, scavenger receptors, and cholesterol efflux transporters, all of which... -
- CITED
-
- Close
- SHARE
-
- Close
- Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components
-
Kim MB, Lee J, Lee JY
- KMID: 2559855
- J Lipid Atheroscler.
- 2024 Sep;13(3):306-327.
- doi: 10.12997/jla.2024.13.3.306
Dysfunctional mitochondria have been linked to the pathogenesis of obesity-associated metabolic diseases. Excessive energy intake impairs mitochondrial biogenesis and function, decreasing adenosine-5’-triphosphate production and negatively impacting metabolically active tissues such... -
- CITED
-
- Close
- SHARE
-
- Close
- Mendelian Randomization Studies in Atherosclerotic Cardiovascular Diseases
-
Ko DS, Kim YH
- KMID: 2559853
- J Lipid Atheroscler.
- 2024 Sep;13(3):280-291.
- doi: 10.12997/jla.2024.13.3.280
This review aimed to highlight the pivotal role of Mendelian randomization (MR) in advancing atherosclerotic cardiovascular disease (ASCVD) research—a field often hindered by the complexities and limitations of traditional studies.... -
- CITED
-
- Close
- SHARE
-
- Close
- Adherence to Dietary Patterns and Cardiovascular Disease Risk: A CrossSectional Study of Total Carotid Plaque Area in Argentina
-
Carrillo MN, Garribia M, Armando L, Adeoye AO, Garcia NH, Muñoz SE
- KMID: 2559857
- J Lipid Atheroscler.
- 2024 Sep;13(3):338-347.
- doi: 10.12997/jla.2024.13.3.338
Objective: Assessing subclinical atherosclerosis (sAT) is crucial for preventing cardiovascular disease. The Mediterranean diet is considered the gold standard for cardiovascular protection, but cultural and economic barriers can hinder adherence... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Multiple Equations for Low-Density Lipoprotein Cholesterol Calculation Against the Direct Homogeneous Method
-
Alsadig RE, Morsi AN
- KMID: 2559858
- J Lipid Atheroscler.
- 2024 Sep;13(3):348-357.
- doi: 10.12997/jla.2024.13.3.348
Objective: Several equations have been proposed as alternatives for the reference method of measuring low-density lipoprotein cholesterol (LDL-C). This study aimed to evaluate these alternatives in comparison to the homogeneous... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease
-
Nakagami H, Hayashi H, Morishita R
- KMID: 2559856
- J Lipid Atheroscler.
- 2024 Sep;13(3):328-337.
- doi: 10.12997/jla.2024.13.3.328
To combat the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), novel vaccine modalities, such as messenger RNA vaccines, were rapidly developed and have shown high efficacy. This new... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Anti-thyroid Drugs on Lipoproteins and Insulin Resistance in Graves’ Disease: A Randomized Clinical Trial
-
Wisnu W, Alwi I, Nafrialdi N, Pemayun TGD, Pantoro NI, Wijaya CN, Tahapary DL, Tarigan TJE, Subekti I
- KMID: 2559859
- J Lipid Atheroscler.
- 2024 Sep;13(3):358-370.
- doi: 10.12997/jla.2024.13.3.358
Objective: Graves’ disease (GD) is characterized by thyroid overactivity. Anti-thyroid drugs (ATDs), such as propylthiouracil (PTU) and methimazole (MMI), are commonly used for GD treatment, and studies have suggested a... -
- CITED
-
- Close
- SHARE
-
- Close
